1
NATERA INC
COM
NTRA
NTRA
796,375
$134.5m13.56%
13.56%
Reduced Shares held: Q3 2024 870.2k, Q4 2024 876.8k, Q1 2025 893.7k, Q2 2025 796.4k
-97.3k
-97,346
-10.9%
2
GSK PLC
SPONSORED ADR
GSK
GSK
2,242,388
$86.1m8.68%
8.68%
Reduced Shares held: Q3 2024 4.1m, Q4 2024 3.7m, Q1 2025 2.6m, Q2 2025 2.2m
-380.9k
-380,858
-14.5%
3
VERA THERAPEUTICS INC
CL A
VERA
VERA
2,383,055
$56.1m5.66%
5.66%
Added Shares held: Q3 2024 2.1m, Q4 2024 1.6m, Q1 2025 1.9m, Q2 2025 2.4m
+484.3k
+484,251
25.5%
4
REVVITY INC
COM
RVTY
RVTY
510,330
$49.4m4.97%
4.97%
Added Shares held: Q3 2024 469.7k, Q4 2024 392.5k, Q1 2025 299.1k, Q2 2025 510.3k
+211.2k
+211,243
70.6%
5
VAXCYTE INC
COM
PCVX
PCVX
1,298,514
$42.2m4.25%
4.25%
Added Shares held: Q3 2024 0, Q4 2024 127.6k, Q1 2025 557.1k, Q2 2025 1.3m
+741.4k
+741,444
133.1%
6
HCA HEALTHCARE INC
COM
HCA
HCA
99,983
$38.3m3.86%
3.86%
Reduced Shares held: Q3 2024 129.1k, Q4 2024 175.8k, Q1 2025 152.5k, Q2 2025 100.0k
-52.5k
-52,519
-34.4%
7
SYNDAX PHARMACEUTICALS INC
COM
SNDX
SNDX
4,065,355
$38.1m3.84%
3.84%
Reduced Shares held: Q3 2024 4.1m, Q4 2024 343.4k, Q1 2025 4.2m, Q2 2025 4.1m
-146.9k
-146,915
-3.5%
8
BRUKER CORP
COM
BRKR
BRKR
839,284
$34.6m3.48%
3.48%
Added Shares held: Q3 2024 0, Q4 2024 234.9k, Q1 2025 499.2k, Q2 2025 839.3k
+340.1k
+340,077
68.1%
9
VIRIDIAN THERAPEUTICS INC
COM
VRDN
VRDN
1,902,539
$26.6m2.68%
2.68%
Added Shares held: Q3 2024 691.2k, Q4 2024 780.0k, Q1 2025 1.4m, Q2 2025 1.9m
+524.9k
+524,865
38.1%
10
IONIS PHARMACEUTICALS INC
COM
IONS
IONS
588,900
$23.3m2.34%
2.34%
Added Shares held: Q3 2024 471.4k, Q4 2024 215.0k, Q1 2025 517.0k, Q2 2025 588.9k
+71.9k
+71,879
13.9%
11
CENTENE CORP DEL
COM
CNC
CNC
398,726
$21.6m2.18%
2.18%
Added Shares held: Q3 2024 135.0k, Q4 2024 188.5k, Q1 2025 340.3k, Q2 2025 398.7k
+58.4k
+58,387
17.2%
12
INSPIRE MED SYS INC
COM
INSP
INSP
164,473
$21.3m2.15%
2.15%
Reduced Shares held: Q3 2024 276.3k, Q4 2024 294.3k, Q1 2025 186.4k, Q2 2025 164.5k
-22.0k
-21,952
-11.8%
13
COMMUNITY HEALTH SYS INC NEW
COM
CYH
CYH
6,144,384
$20.9m2.11%
2.11%
Reduced Shares held: Q3 2024 8.8m, Q4 2024 2.8m, Q1 2025 8.5m, Q2 2025 6.1m
-2.3m
-2,313,636
-27.4%
14
AVANTOR INC
COM
AVTR
AVTR
1,526,164
$20.5m2.07%
2.07%
Added Shares held: Q3 2024 168.4k, Q4 2024 168.4k, Q1 2025 122.8k, Q2 2025 1.5m
+1.4m
+1,403,341
1142.6%
15
BIO-TECHNE CORP
COM
TECH
TECH
394,139
$20.3m2.04%
2.04%
Added Shares held: Q3 2024 663.6k, Q4 2024 299.3k, Q1 2025 280.1k, Q2 2025 394.1k
+114.0k
+114,022
40.7%
16
TRAVERE THERAPEUTICS INC
COM
TVTX
TVTX
1,315,033
$19.5m1.96%
1.96%
Added Shares held: Q3 2024 869.9k, Q4 2024 490.3k, Q1 2025 816.3k, Q2 2025 1.3m
+498.8k
+498,779
61.1%
17
ZIMVIE INC
COM
ZIMV
ZIMV
2,079,380
$19.4m1.96%
1.96%
Unchanged Shares held: Q3 2024 2.1m, Q4 2024 2.1m, Q1 2025 2.1m, Q2 2025 2.1m
18
UNITEDHEALTH GROUP INC
COM
UNH
UNH
60,736
$18.9m1.91%
1.91%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 60.7k
19
ILLUMINA INC
COM
ILMN
ILMN
198,584
$18.9m1.91%
1.91%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 198.6k
20
TEVA PHARMACEUTICAL INDS LTD
SPONSORED ADS
SPONSORED ADS
1,052,881
$17.6m1.78%
1.78%
Reduced Shares held: Q3 2024 3.2m, Q4 2024 2.2m, Q1 2025 1.4m, Q2 2025 1.1m
-357.9k
-357,884
-25.4%
21
CELLDEX THERAPEUTICS INC NEW
COM NEW
CLDX
CLDX
838,736
$17.1m1.72%
1.72%
Added Shares held: Q3 2024 564.9k, Q4 2024 719.8k, Q1 2025 696.5k, Q2 2025 838.7k
+142.2k
+142,237
20.4%
22
UNITED THERAPEUTICS CORP DEL
COM
UTHR
UTHR
59,366
$17.1m1.72%
1.72%
Added Shares held: Q3 2024 130.9k, Q4 2024 43.7k, Q1 2025 57.5k, Q2 2025 59.4k
+1.9k
+1,877
3.3%
23
HEALTHEQUITY INC
COM
HQY
HQY
155,868
$16.3m1.65%
1.65%
Reduced Shares held: Q3 2024 319.1k, Q4 2024 386.7k, Q1 2025 352.0k, Q2 2025 155.9k
-196.1k
-196,108
-55.7%
24
IQVIA HLDGS INC
COM
IQV
IQV
97,604
$15.4m1.55%
1.55%
New Shares held: Q3 2024 13.1k, Q4 2024 0, Q1 2025 0, Q2 2025 97.6k
25
PROTAGONIST THERAPEUTICS INC
COM
PTGX
PTGX
277,316
$15.3m1.54%
1.54%
Reduced Shares held: Q3 2024 445.2k, Q4 2024 678.8k, Q1 2025 547.1k, Q2 2025 277.3k
-269.8k
-269,800
-49.3%
26
DYNAVAX TECHNOLOGIES CORP
COM NEW
DVAX
DVAX
1,197,189
$11.9m1.20%
1.20%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 1.2m
27
MIRUM PHARMACEUTICALS INC
COM
MIRM
MIRM
232,175
$11.8m1.19%
1.19%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 232.2k
28
BIOCRYST PHARMACEUTICALS INC
COM
BCRX
BCRX
1,207,638
$10.8m1.09%
1.09%
Reduced Shares held: Q3 2024 535.4k, Q4 2024 2.0m, Q1 2025 2.2m, Q2 2025 1.2m
-964.8k
-964,798
-44.4%
29
EVOLUS INC
COM
EOLS
EOLS
1,170,311
$10.8m1.09%
1.09%
New Shares held: Q3 2024 453.1k, Q4 2024 383.0k, Q1 2025 0, Q2 2025 1.2m
30
HUMANA INC
COM
HUM
HUM
43,620
$10.7m1.07%
1.07%
Added Shares held: Q3 2024 33.9k, Q4 2024 22.7k, Q1 2025 28.0k, Q2 2025 43.6k
+15.7k
+15,650
56.0%
31
GERON CORP
COM
GERN
GERN
7,320,174
$10.3m1.04%
1.04%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 7.3m
32
GLOBUS MED INC
CL A
GMED
GMED
169,643
$10.0m1.01%
1.01%
Reduced Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 192.9k, Q2 2025 169.6k
-23.2k
-23,250
-12.1%
33
ICON PLC
SHS
ICLR
ICLR
64,587
$9.4m0.95%
0.95%
Added Shares held: Q3 2024 13.7k, Q4 2024 19.3k, Q1 2025 10.8k, Q2 2025 64.6k
+53.7k
+53,747
495.8%
34
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
NAMS
NAMS
414,430
$7.5m0.76%
0.76%
Added Shares held: Q3 2024 307.4k, Q4 2024 275.4k, Q1 2025 281.0k, Q2 2025 414.4k
+133.5k
+133,479
47.5%
35
ELEVANCE HEALTH INC
COM
ELV
ELV
18,962
$7.4m0.74%
0.74%
Added Shares held: Q3 2024 19.5k, Q4 2024 29.2k, Q1 2025 15.7k, Q2 2025 19.0k
+3.3k
+3,264
20.8%
36
REGENERON PHARMACEUTICALS
COM
REGN
REGN
13,254
$7.0m0.70%
0.70%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.3k
37
MERUS N V
COM
MRUS
MRUS
130,924
$6.9m0.69%
0.69%
Added Shares held: Q3 2024 68.3k, Q4 2024 68.3k, Q1 2025 70.3k, Q2 2025 130.9k
+60.6k
+60,595
86.2%
38
MOLINA HEALTHCARE INC
COM
MOH
MOH
20,600
$6.1m0.62%
0.62%
Reduced Shares held: Q3 2024 10.6k, Q4 2024 0, Q1 2025 23.7k, Q2 2025 20.6k
-3.1k
-3,135
-13.2%
39
THERMO FISHER SCIENTIFIC INC
COM
TMO
TMO
13,685
$5.5m0.56%
0.56%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.7k
40
EDGEWISE THERAPEUTICS INC
COM
EWTX
EWTX
392,739
$5.1m0.52%
0.52%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 392.7k
41
DANAHER CORPORATION
COM
DHR
DHR
23,449
$4.6m0.47%
0.47%
New Shares held: Q3 2024 38.4k, Q4 2024 22.2k, Q1 2025 0, Q2 2025 23.4k
42
LIQUIDIA CORPORATION
COM NEW
LQDA
LQDA
358,828
$4.5m0.45%
0.45%
Added Shares held: Q3 2024 137.9k, Q4 2024 571.3k, Q1 2025 150.5k, Q2 2025 358.8k
+208.3k
+208,348
138.5%
43
GLAUKOS CORP
COM
GKOS
GKOS
31,496
$3.3m0.33%
0.33%
Reduced Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 159.0k, Q2 2025 31.5k
-127.5k
-127,461
-80.2%
44
ZENAS BIOPHARMA INC
COM
ZBIO
ZBIO
325,479
$3.2m0.32%
0.32%
Reduced Shares held: Q3 2024 190.5k, Q4 2024 172.1k, Q1 2025 445.6k, Q2 2025 325.5k
-120.1k
-120,109
-27.0%
45
NEKTAR THERAPEUTICS
COM NEW
NKTR
NKTR
115,000
$3.0m0.30%
0.30%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 115.0k
46
ALECTOR INC
COM
ALEC
ALEC
1,986,072
$2.8m0.28%
0.28%
Added Shares held: Q3 2024 332.8k, Q4 2024 200.1k, Q1 2025 617.4k, Q2 2025 2.0m
+1.4m
+1,368,654
221.7%
47
AMARIN CORP PLC
SPONSORED ADR
AMRN
AMRN
167,276
$2.7m0.27%
0.27%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 167.3k
48
MANNKIND CORP
COM NEW
MNKD
MNKD
697,710
$2.6m0.26%
0.26%
Unchanged Shares held: Q3 2024 2.0m, Q4 2024 911.0k, Q1 2025 697.7k, Q2 2025 697.7k
49
89BIO INC
COM
ETNB
ETNB
235,990
$2.3m0.23%
0.23%
Reduced Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 303.7k, Q2 2025 236.0k
-67.7k
-67,741
-22.3%
50
REPLIGEN CORP
COM
RGEN
RGEN
18,620
$2.3m0.23%
0.23%
Added Shares held: Q3 2024 163.6k, Q4 2024 54.1k, Q1 2025 18.5k, Q2 2025 18.6k
+168
+168
0.9%
51
GOSSAMER BIO INC
COM
GOSS
GOSS
1,695,762
$2.1m0.21%
0.21%
Reduced Shares held: Q3 2024 5.0m, Q4 2024 5.0m, Q1 2025 3.9m, Q2 2025 1.7m
-2.2m
-2,201,079
-56.5%
52
STRUCTURE THERAPEUTICS INC
SPONSORED ADS
GPCR
GPCR
99,338
$2.1m0.21%
0.21%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 99.3k
53
RELAY THERAPEUTICS INC
COM
RLAY
RLAY
533,409
$1.8m0.19%
0.19%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 533.4k
54
SUTRO BIOPHARMA INC
COM
COM
2,292,261
$1.6m0.16%
0.16%
Unchanged Shares held: Q3 2024 1.8m, Q4 2024 694.4k, Q1 2025 2.3m, Q2 2025 2.3m
55
MARAVAI LIFESCIENCES HLDGS I
COM CL A
MRVI
MRVI
640,673
$1.5m0.16%
0.16%
Reduced Shares held: Q3 2024 337.0k, Q4 2024 0, Q1 2025 942.5k, Q2 2025 640.7k
-301.8k
-301,781
-32.0%
56
BICYCLE THERAPEUTICS PLC
SPONSORED ADS
BCYC
BCYC
211,469
$1.5m0.15%
0.15%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 211.5k
57
AUTOLUS THERAPEUTICS PLC
SPON ADS
AUTL
AUTL
610,231
$1.4m0.14%
0.14%
Added Shares held: Q3 2024 406.6k, Q4 2024 98.9k, Q1 2025 343.9k, Q2 2025 610.2k
+266.3k
+266,284
77.4%
58
INFLARX NV
COM
IFRX
IFRX
1,640,430
$1.3m0.13%
0.13%
Reduced Shares held: Q3 2024 1.6m, Q4 2024 492.5k, Q1 2025 1.7m, Q2 2025 1.6m
-35.5k
-35,548
-2.1%
59
PENNANT GROUP INC
COM
PNTG
PNTG
37,980
$1.1m0.11%
0.11%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 38.0k
60
KARYOPHARM THERAPEUTICS INC
COM NEW
KPTI
KPTI
257,154
$1.1m0.11%
0.11%
Unchanged Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 257.2k, Q2 2025 257.2k
61
ITEOS THERAPEUTICS INC
COM
ITOS
ITOS
109,324
$1.1m0.11%
0.11%
Reduced Shares held: Q3 2024 0, Q4 2024 220.2k, Q1 2025 220.2k, Q2 2025 109.3k
-110.9k
-110,872
-50.4%
62
FORTREA HLDGS INC
COMMON STOCK
FTRE
FTRE
219,384
$1.1m0.11%
0.11%
Reduced Shares held: Q3 2024 458.0k, Q4 2024 401.7k, Q1 2025 293.3k, Q2 2025 219.4k
-73.9k
-73,891
-25.2%
63
PUMA BIOTECHNOLOGY INC
COM
PBYI
PBYI
240,688
$825.6k0.08%
0.08%
Reduced Shares held: Q3 2024 1.3m, Q4 2024 996.1k, Q1 2025 275.8k, Q2 2025 240.7k
-35.1k
-35,100
-12.7%
64
ARCTURUS THERAPEUTICS HLDGS
COM
ARCT
ARCT
48,364
$629.2k0.06%
0.06%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 48.4k
65
EHEALTH INC
COM
EHTH
EHTH
128,322
$558.2k0.06%
0.06%
Added Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 89.2k, Q2 2025 128.3k
+39.1k
+39,102
43.8%
66
MODIVCARE INC
COM
MODVQ
MODVQ
100,000
$312.0k0.03%
0.03%
New Shares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 100.0k
67
AC IMMUNE SA
SHS
ACIU
ACIU
100,752
$204.5k0.02%
0.02%
Unchanged Shares held: Q3 2024 99.3k, Q4 2024 0, Q1 2025 100.8k, Q2 2025 100.8k